Register entry

Novartis Pharma Produktions GmbH

Data as of · How to read this entry

Registered sites
0
Active NDC listings
12
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

12

12 active NDC listings: 12 human prescription drug. By marketing category: DRUG FOR FURTHER PROCESSING 12.

Dosage formNDCs
tablet, film coated4
tablet, extended release3
tablet2
tablet, delayed release2
capsule1
RouteNDCs
Labeller name on the listingNDCs
novartis pharma produktions gmbh12
Catalogue

Marketed products

12
BrandGeneric nameForm / routeNDC
-capmatinibtablet, film coated66828-0275DRUG FOR FURTHER PROCESSING
-capmatinibtablet, film coated66828-0317DRUG FOR FURTHER PROCESSING
-carbamazepinetablet, extended release66828-0261DRUG FOR FURTHER PROCESSING
-carbamazepinetablet, extended release66828-0268DRUG FOR FURTHER PROCESSING
-carbamazepinetablet, extended release66828-0324DRUG FOR FURTHER PROCESSING
-ceritinibtablet, film coated66828-0254DRUG FOR FURTHER PROCESSING
-imatinib mesylatetablet66828-0303DRUG FOR FURTHER PROCESSING
-imatinib mesylatetablet66828-0310DRUG FOR FURTHER PROCESSING
-iptacopancapsule66828-0247DRUG FOR FURTHER PROCESSING
-mycophenolic acidtablet, delayed release66828-0289DRUG FOR FURTHER PROCESSING
-mycophenolic acidtablet, delayed release66828-0296DRUG FOR FURTHER PROCESSING
-pazopanib hydrochloridetablet, film coated66828-0282DRUG FOR FURTHER PROCESSING
Compare

Other companies listing carbamazepine

Enquiry

Common questions

Is Novartis Pharma Produktions GmbH FDA approved?
Novartis Pharma Produktions GmbH holds no registered establishment of its own; 12 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Novartis Pharma Produktions GmbH make?
12 products are listed under Novartis Pharma Produktions GmbH in the openFDA NDC Directory, most often as tablet, film coated; tablet, extended release; tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.